Day: November 13, 2019

Oslo, 13. november 2019: Yara annonserer stenging av sin heleide fabrikk i Point Lisas, Trinidad. Fabrikken er ett av tre ammoniakkanlegg drevet av Yara Trinidad Ltd. De to gjenværende anleggene, Tringen I og Tringen II, er eid av Yara sammen med National Enterprises Ltd (NEL). Fabrikken i Trinidad er en av Yara sine minste ammoniakkanlegg, med en årlig produksjonskapasitet på omtrent 270.000 tonn ammoniakk. I tillegg til begrenset skala har fabrikken lavere energieffektivitet enn gjennomsnittet av Yaras fabrikker. Fabrikkens lønnsomhet har dessuten vært påvirket av fallende ammoniakkpriser, og i tillegg har forhandlingene med The National Gas Company of Trinidad and Tobago (NGC) ikke lykkes i å oppnå en avtale som kunne sikret videre drift av fabrikken. Yara vil iverksette tiltak for å stenge fabrikken og avslutte produksjonen innen...

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIALEtabli en application de l’article 223-16 du règlement général de l’Autorité des Marchés Financiers* Total net : nombre total de droits de vote attachés au nombre total d’actions moins les actions privées de droit de vote (autodétention)A propos de RIBER :RIBER est un leader mondial d’équipement pour l’industrie des semiconducteurs. L’entreprise conçoit et fabrique des systèmes d’épitaxie par jets moléculaires (MBE) ainsi que des évaporateurs destinés à l’industrie des semi-conducteurs. Elle offre également à ses clients un support technique et scientifique en assurant la maintenance de ses équipements, l’optimisation de leurs performances et de leurs rendements. A travers ses équipements de haute technologie, RIBER joue un rôle essentiel...

Volta Finance Limited (VTA / VTAS) – October 2019 monthly reportNOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES*****Guernsey, 13 November 2019AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for October. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com).PERFORMANCE and PORTFOLIO ACTIVITYIn October, Volta’s NAV* total return performance was -2.6%. The YTD performance is 3.1%.This relatively modest performance YTD is mostly due to the widening of discount margins in the CLO market although there has been a significant difference in the recent performances of CLO debt and CLO Equity.Indeed, the monthly performances ** of the sub-asset classes were the following, in local...

VALCOURT, Quebec, Nov. 13, 2019 (GLOBE NEWSWIRE) — BRP Inc. (TSX:DOO; NASDAQ:DOOO) will hold its third quarter FY2020 financial results conference call on Wednesday, November 27, 2019.José Boisjoli, President and Chief Executive Officer, and Sébastien Martel, Chief Financial Officer, will present the results of the third quarter of FY2020 and address questions from analysts on a conference call at 9 a.m. (EST).The press release will be distributed on Canadian and American newswires on Wednesday, November 27 at approximately 6 a.m. (EST).For investors and analysts:Business media are allowed to join the call but will not be permitted to ask questions. This webcast will also be live on the Internet here and accessible to media and interested participants. An archived recording will be available here two hours after the event for 30...

VALCOURT, Québec, 13 nov. 2019 (GLOBE NEWSWIRE) — BRP Inc. (TSX: DOO; NASDAQ: DOOO) tiendra un appel conférence sur les résultats financiers de son troisième trimestre de l’année financière 2020 le mercredi 27 novembre 2019.José Boisjoli, président et chef de la direction, et Sébastien Martel, chef de la direction financière, présenteront les résultats du troisième trimestre de l’AF2020 et répondront aux questions des analystes à 9 h (HNE).Le communiqué de presse sera diffusé sur les fils de presse canadien et américain le mercredi 27 novembre, vers 6 h (HNE).Pour les investisseurs et les analystes :Les médias sont autorisés à participer à l’appel, mais ne pourront poser de questions. Cette webdiffusion sera également retransmise en direct sur Internet ici et accessible aux médias et aux participants intéressés. Un enregistrement...

LAKE FOREST, Ill., Nov. 13, 2019 (GLOBE NEWSWIRE) — Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the Stifel Healthcare Conference in a session scheduled for 10:20 a.m. ET, Wednesday, November 20, 2019 in New York, NY.This presentation will be webcast and can be accessed via the Investor Relations page of the Assertio website at http://investor.assertiotx.com. Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software. A recording of the webcast will be archived.About Assertio Therapeutics, Inc.Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines. Assertio currently markets three FDA-approved...

Présentation de données supplémentaires à la FDA concernant la stabilité du transport de l’EB-101 en réponse à la lettre de suspension d’essai clinique ; autorisation CMC pour la phase 3 pivot de l’essai VIITALTM attendue au quatrième trimestre 2019La publication de données positives à long-terme pour l’EB-101 a confirmé une cicatrisation complète des plaies, un soulagement de la douleur et des démangeaisons, et un traitement au profil d’innocuité avantageux après trois ansRévision stratégique continue de diverses initiativesLa société organisera une conférence téléphonique pour les investisseurs le mercredi 13 novembre à 10h00 HNENEW YORK et CLEVELAND, 13 nov. 2019 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq : ABEO), leader entièrement intégré de la thérapie génique et cellulaire, a annoncé...

Zusätzliche EB-101-Transportstabilitätsdaten als Reaktion auf Clinical Hold Letter an die FDA übermittelt; CMC-Freigabe für die zulassungsrelevante VIITALTM  Phase 3-Studie in Q4 2019 erwartetDie Veröffentlichung positiver Langzeitdaten für EB-101 zeigte eine nachhaltige Wundheilung, Schmerzlinderung und Juckreiz sowie ein günstiges Sicherheitsprofil drei Jahre nach der BehandlungLaufende strategische Überprüfung einer großen Anzahl von InitiativenUnternehmen veranstaltet Investoren-Telefonkonferenz Mittwoch, 13. November um 10:00 Uhr Eastern TimeNEW YORK und CLEVELAND, Nov. 13, 2019 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), ein voll integrierter Marktführer in der Gen- und Zelltherapie, gab heute die Finanzergebnisse und Geschäftsergebnisse des dritten Quartals 2019 bekannt, die in einer Telefonkonferenz am Mittwoch,...

GRAND HAVEN, Mich., Nov. 13, 2019 (GLOBE NEWSWIRE) — Access-Power, Inc., (“ACCR or the Company”), a Grand Haven based medical marijuana clone corporation is pleased to announce that our website is LIVE!We opened up our beta test website for test ONLINE ORDERs today. Customers can purchase our product, and once paid, we will send their product by Drones! Have fun! We have the orders being placed in test mode on COD basis for now while we test. Customers can place an order, and we will send you the order confirmation after placing your order.Customers can visit us at http://www.clonesbydrones.com and place their order for one of the top legendary strains cloned from our original seed vault, to also include crowd favorites like Lemon Haze OG™, Candy Kush™, and also Bubblelicious™ in addition to about 20 (twenty) other varieties of...

GADSDEN, Ala., Nov. 13, 2019 (GLOBE NEWSWIRE) — The Southern Banc Company, Inc. (OTCBB: SRNN), the holding company for The Southern Bank Company, formerly First Federal Savings and Loan Association of Gadsden, Alabama, announced a net income of $126,221, or $0.16 per basic and diluted share, for the quarter ended September 30, 2019, as compared to a net income $125,807, or $0.16 per basic and diluted share, for the quarter ended September 30, 2018. Gates Little, President and Chief Executive Officer of the Company stated that the Company’s net interest margins decreased by approximately $12,000 or (1.06%) during the quarter as compared to the same period in 2018. Net interest income before provision for loan losses was approximately $1.2 million for the quarters ended September 30, 2019 and 2018, respectively. For the three-months...